Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
NCT06347627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1324
Last updated 2026-05-15
Summary
This study aims to comprehensively assess confidence in and acceptance of human papillomavirus (HPV) vaccines among Japanese parents and caregivers with daughters aged 12-18 and their decision-making process.
Conditions
- Healthy
Interventions
- BEHAVIORAL
-
Group 1 (I x S x S x F)
Experimental message: Individual x Safety x Storytelling x Factual
- BEHAVIORAL
-
Group 2 (O x S x S x F)
Experimental message: Organization x Safety x Storytelling x Factual
- BEHAVIORAL
-
Group 3 (I x E x S x F)
Experimental message: Individual x Effectiveness x Storytelling x Factual
- BEHAVIORAL
-
Group 4 (O x E x S x F)
Experimental message: Organization x Effectiveness x Storytelling x Factual
- BEHAVIORAL
-
Group 5 (I x S x S x M)
Experimental message: Individual x Safety x Storytelling x Misinformation
- BEHAVIORAL
-
Group 6 (O x S x S x M)
Experimental message: Organization x Safety x Storytelling x Misinformation
- BEHAVIORAL
-
Group 7 (I x E x S x M)
Experimental message: Individual x Effectiveness x Storytelling x Misinformation
- BEHAVIORAL
-
Group 8 (O x E x S x M)
Experimental message: Organization x Effectiveness x Storytelling x Misinformation
- BEHAVIORAL
-
Group 9 (I x S x D x F)
Experimental message: Individual x Safety x Scientific data x Factual
- BEHAVIORAL
-
Group 10 (O x S x D x F)
Experimental message: Organization x Safety x Scientific data x Factual
- BEHAVIORAL
-
Group 11 (I x E x D x F)
Experimental message: Individual x Effectiveness x Scientific data x Factual
- BEHAVIORAL
-
Group 12 (O x E x D x F)
Experimental message: Organization x Effectiveness x Scientific data x Factual
- BEHAVIORAL
-
Group 13 (I x S x D x M)
Experimental message: Individual x Safety x Scientific data x Misinformation
- BEHAVIORAL
-
Group 14 (O x S x D x M)
Experimental message: Organization x Safety x Scientific data x Misinformation
- BEHAVIORAL
-
Group 15 (I x E x D x M)
Experimental message: Individual x Effectiveness x Scientific data x Misinformation
- BEHAVIORAL
-
Group 16 (O x E x D x M)
Experimental message: Organization x Effectiveness x Scientific data x Misinformation
Sponsors & Collaborators
-
London School of Hygiene and Tropical Medicine
collaborator OTHER -
Nagasaki University
collaborator OTHER -
The University of Hong Kong
lead OTHER
Principal Investigators
-
Leesa Lin, PhD · London School of Hygiene and Tropical Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- TRIPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-12-22
- Primary Completion
- 2024-01-22
- Completion
- 2024-01-22
Countries
- United Kingdom
Study Locations
More Related Trials
-
Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
NCT03209713 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics
NCT03111251 ·Status: COMPLETED ·Phase: NA
-
Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents
NCT06155877 ·Status: COMPLETED ·Phase: NA
-
An Online Intervention Promoting HPV Vaccination Among Chinese MSM
NCT04815837 ·Status: COMPLETED ·Phase: NA
-
Social Media-based Vaccine Confidence and Hesitancy Monitoring
NCT05442762 ·Status: WITHDRAWN
-
Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
NCT01389687 ·Status: COMPLETED ·Phase: PHASE3
-
A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
NCT00501137 ·Status: COMPLETED ·Phase: PHASE3
-
HPV Prevalence in 16-20 Year Old Males
NCT04297670 ·Status: UNKNOWN
-
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
NCT04648241 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines
NCT00891176 ·Status: COMPLETED ·Phase: PHASE3
-
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
NCT00463437 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children
NCT01428908 ·Status: COMPLETED ·Phase: PHASE3
-
Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV
NCT03614702 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children
NCT01406509 ·Status: COMPLETED ·Phase: PHASE1
-
Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014
NCT00614614 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
NCT00604708 ·Status: COMPLETED ·Phase: PHASE3
-
Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)
NCT01463683 ·Status: COMPLETED ·Phase: PHASE3
-
Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine
NCT01475539 ·Status: COMPLETED ·Phase: PHASE4
-
Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
NCT00131833 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers
NCT01323647 ·Status: COMPLETED ·Phase: PHASE3
-
The Acceptability of the HPV Vaccine Postpartum and With Pediatric Well-child Visits: A Pilot Study
NCT02602626 ·Status: COMPLETED
-
To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis
NCT06825312 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine
NCT00508261 ·Status: COMPLETED ·Phase: PHASE3
-
Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan
NCT02005536 ·Status: COMPLETED ·Phase: PHASE4